Cell Therapy Systems KnockOut™ DMEM/F-12 CTS™ is a serum free, low osmolality medium without L-glutamine or HEPES buffer that is optimized for the growth of human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC). KnockOut™ DMEM/F-12 CTS™ media is designed for use with KnockOut™ SR and KnockOut™ SR XenoFree CTS™ supplements.
Designed for reliable and consistent performance
• Perform ESC/iPSC culturing with little to no spontaneous differentiation • Be ready for clinical research with this cGmP manufactured formula and support documentation
Consistent Results Without Fetal Bovine Serum Cell Therapy Systems KnockOut™ DMEM/F-12 CTS™ media is part of the KnockOut™ line of media products that have delivered reliable results for ESC and now iPSC culturing for years. This fetal bovine free media leads to little or no spontaneous differentiation, and frees you from repeated screens.
Equivalent Morphology Stem cells cultured in KnockOut™ DMEM/F-12 CTS™ media show normal morphology and karyotype when compared to control stem cells. You can also expect equivalent morphology to manually passaged hESCs, even after enzymatic passaging.
Simplify Your Transition into Clinical Research The Gibco® Cell Therapy Systems (CTS™) brand offers a broad array of products for use in cell therapy applications, including media, reagents, growth factors, enzymes, cell selection/expansion reagents, and devices. Gibco® Cell Therapy Systems (CTS™) products deliver: • Reduced burden in qualifying reagents • Included appropriate certificates of analyses and origin • Convenient access to our Drug Master File (DMF)
For Research Use or Non-Commercial Manufacturing of Cell-Based Products for Clinical Research.
原厂资料：
注意事项：
CAUTION: Not intended for direct administration to humans or animals
京公网安备11010802025653 版权所有：北京逸优科技有限公司
